Anti-LAG-3 antibodies and compositions
US11390676B2 · kind B2 · utility
2Cited by
0References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 13, 2017 |
| Grant date | Jul 19, 2022 |
| Priority date | — |
| Expiry date | May 5, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to anti-LAG-3 antibodies and methods of using them in treating diseases and conditions that benefit from modulating LAG-3 activity, e.g., cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.